Subscribe to RSS
DOI: 10.1055/s-0029-1243076
Cosmeceuticals for Rejuvenation
Publication History
Publication Date:
18 December 2009 (online)
![](https://www.thieme-connect.de/media/fps/200905/lookinside/thumbnails/10.1055-s-0029-1243076-1.jpg)
ABSTRACT
Facial plastic surgeons are frequently called upon to enhance the appearance of their patients. Typically, this involves surgery of the face or neck. Increasingly, this may also require the use of injectables such as botulinum toxins, fillers, and volumizers. Lasers and light sources are used to enhance the appearance of the surface of the skin. Each of these modalities will help to improve the patient but are limited by the fact that they require the patient to be treated in the office. With the advent of effective topical agents, patients are increasingly able to improve their appearance with the use of prescription and nonprescription topical products. It is incumbent upon the facial plastic surgeon to have an understanding of these topical agents so that they can assist the patient in deciding what does and does not make sense. In addition, many cosmetic physicians will dispense these products in their office, and it behooves them to understand the various products available and what will likely be produced in the future.
KEYWORDS
Cosmeceuticals - tretinoin - coffeeberry - antioxidant - green tea - peptides - bamboo - vitamin C
REFERENCES
- 1 Sachs D L, Kang S, Hammerberg C et al.. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis. Arch Dermatol. 2009; 145 659-666
- 2 Kang S. Photoaging and tretinoin. Dermatol Clin. 1998; 16 357-364
- 3 Lupo M P. Cosmeceutical peptides. Dermatol Surg. 2005; 31(7 Pt 2) 832-836 discussion 836
- 4 Katayama K, Armendariz-Borunda J, Raghow R, Kang A H, Seyer J M. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem. 1993; 268 9941-9944
- 5 Glogau R G. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg. 2007; 33(1 Spec No) S76-S80
- 6 Lupo M P, Cole A L. Cosmeceutical peptides. Dermatol Ther. 2007; 20 343-349
- 7 Fisher G J, Wang Z Q, Datta S C, Varani J, Kang S, Voorhees J J. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997; 337 1419-1428
- 8 Janjua R, Munoz C, Gorell E et al.. A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatol Surg. 2009; 35 1057-1065
- 9 Stiefel Laboratories .Data on file. Stiefel Laboratories; Internal Document 2007
- 10 Farris P. Idebenone, green tea, and coffeeberry extracts: new and innovative antioxidants. Dermatol Ther. 2007; 20 322-329
- 11 Pinnell S R, Yang H, Omar M et al.. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001; 27 137-142
- 12 Nusgens B V, Humbert P, Rougier A et al.. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001; 116 853-859
- 13 Baumann L. Botanical ingredients in cosmeceuticals. J Drugs Dermatol. 2007; 6 1084-1088
- 14 Baumann L, Woolery-Lloyd H, Friedman A. “Natural” ingredients in cosmetic dermatology. J Drugs Dermatol. 2009; 8(6 Suppl) s5-s9
- 15 Narukar V, Cohen J, Beer K. American Society for Dermatologic Surgery. Orlando, FL; 2009
- 16 Fitzpatrick R E, Rostan E F. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003; 5 25-34
Kenneth BeerM.D. F.A.A.D.
Palm Beach Esthetic Dermatology and Laser Center
1500 North Dixie Highway, Suite #305, West Palm Beach, FL 33401
Email: KenBeer@aol.com